HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
SCAP
SREBF chaperone
Chromosome 3 · 3p21.31
NCBI Gene: 22937Ensembl: ENSG00000114650.22HGNC: HGNC:30634UniProt: B7Z6H0
95PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
protein bindingregulation of transcription by RNA polymerase IIcholesterol metabolic processSREBP signaling pathwayAbnormality of the skeletal systemdengue diseasecomplicationnervous system disease
✦AI Summary

SCAP (SREBF chaperone) is a polytopic membrane protein that functions as a molecular escort regulating cholesterol and lipid homeostasis 1. SCAP's primary function is to bind sterol regulatory element-binding proteins (SREBPs) and transport the SCAP-SREBP complex from the endoplasmic reticulum (ER) to the Golgi apparatus, enabling SREBP proteolytic processing and activation 1. This transport is tightly regulated by sterol levels: at low cholesterol concentrations, SCAP unmasking of its ER export signal promotes COPII-coated vesicle recruitment and Golgi translocation, where SREBPs are cleaved to release transcription factor fragments that enter the nucleus to upregulate cholesterol synthesis and LDL receptor genes 1. At high sterol concentrations, SCAP forms a ternary complex with INSIG proteins that masks the export signal, retaining the complex in the ER 2. Beyond sterol sensing, SCAP acts as a metabolic sensor responding to ammonia and other signals that promote SCAP-INSIG dissociation and lipid synthesis 3. SCAP also integrates cholesterol biosynthesis with immune function by serving as a signaling hub for NLRP3 inflammasome activation in macrophages 4. Dysregulation of SCAP-mediated cholesterol metabolism occurs in hepatocellular carcinoma through ZDHHC3-mediated S-acylation and PCK1-mediated phosphorylation of INSIG proteins, promoting tumor growth and immune escape 52. SCAP represents a therapeutic target for metabolic and malignant diseases, with SCAP degradation showing promise in treating obesity, hyperlipidemia, and insulin resistance 6.

Sources cited
1
SCAP is a polytopic membrane protein that binds SREBPs and transports them from ER to Golgi for proteolytic processing; four domains undergo conformational changes in response to cholesterol binding to control lipid homeostasis
PMID: 28841344
2
PCK1 phosphorylates INSIG1/2 to disrupt INSIG-SCAP interaction, promoting SCAP-SREBP translocation to Golgi and SREBP activation in cancer cells
PMID: 32322062
3
SCAP-SREBP2 ER-to-Golgi translocation is required for NLRP3 inflammasome activation in macrophages; SCAP serves as a signaling hub integrating cholesterol metabolism with inflammation
PMID: 30366764
4
Ammonia promotes SCAP-INSIG dissociation and SREBP-1 activation to promote lipogenesis and tumor growth; SCAP functions as a sensor of glutamine, glucose, and sterol levels
PMID: 35534729
5
ZDHHC3-mediated SCAP S-acylation antagonizes HACE1-mediated ubiquitination, forming a positive feedback loop in hepatocellular carcinoma that promotes cholesterol biosynthesis and tumor immune escape
PMID: 39522165
6
SCAP degradation via the SQSTM1-mediated autophagy-independent lysosomal degradation pathway ameliorates high-fat diet-induced obesity, hyperlipidemia, and insulin resistance in mice
PMID: 32432943
Disease Associationsⓘ20
Abnormality of the skeletal systemOpen Targets
0.39Weak
dengue diseaseOpen Targets
0.37Weak
complicationOpen Targets
0.27Weak
nervous system diseaseOpen Targets
0.27Weak
Herpes ZosterOpen Targets
0.27Weak
neurodegenerative diseaseOpen Targets
0.25Weak
urinary bladder carcinomaOpen Targets
0.15Weak
neoplasmOpen Targets
0.09Suggestive
hepatocellular carcinomaOpen Targets
0.08Suggestive
breast cancerOpen Targets
0.08Suggestive
goutOpen Targets
0.07Suggestive
non-small cell lung carcinomaOpen Targets
0.06Suggestive
obesityOpen Targets
0.06Suggestive
Schnyder corneal dystrophyOpen Targets
0.05Suggestive
atherosclerosisOpen Targets
0.04Suggestive
non-alcoholic fatty liver diseaseOpen Targets
0.04Suggestive
non-alcoholic steatohepatitisOpen Targets
0.04Suggestive
Bartsocas-Papas syndrome 1Open Targets
0.03Suggestive
esophageal squamous cell carcinomaOpen Targets
0.03Suggestive
Hepatic steatosisOpen Targets
0.02Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
RNF139Protein interaction100%MBTPS1Protein interaction95%SEC24BProtein interaction78%OSBPProtein interaction75%ATF6Protein interaction75%NPC2Protein interaction71%
Tissue Expression6 tissues
Liver
100%
Ovary
62%
Lung
45%
Heart
33%
Brain
30%
Bone Marrow
29%
Gene Interaction Network
Click a node to explore
SCAPRNF139MBTPS1SEC24BOSBPATF6NPC2
PROTEIN STRUCTURE
Preparing viewer…
PDB6M49 · 3.70 Å · EM
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
0.67LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.54 [0.45–0.67]
RankingsWhere SCAP stands among ~20K protein-coding genes
  • #5,060of 20,598
    Most Researched95 · top quartile
  • #4,921of 17,882
    Most Constrained (LOEUF)0.67
Genes detectedSCAP
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
Infection and co-infection patterns of community-acquired pneumonia in patients of different ages in China from 2009 to 2020: a national surveillance study.
PMID: 37001538
Lancet Microbe · 2023
1.00
2
The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis.
PMID: 32322062
Nature · 2020
0.90
3
Severe community-acquired pneumonia (sCAP): advances in management and future directions.
PMID: 40360263
Thorax · 2025
0.80
4
Retrospective on Cholesterol Homeostasis: The Central Role of Scap.
PMID: 28841344
Annu Rev Biochem · 2018
0.70
5
Cholesterol Homeostatic Regulator SCAP-SREBP2 Integrates NLRP3 Inflammasome Activation and Cholesterol Biosynthetic Signaling in Macrophages.
PMID: 30366764
Immunity · 2018
0.60